Advertisement







Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1998; 32:147-153
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laine, H.
Right arrow Articles by Knuuti, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laine, H.
Right arrow Articles by Knuuti, J.

CLINICAL STUDIES

Early impairment of coronary flow reserve in young men with borderline hypertension

Hanna Laine, MDa, Olli T. Raitakari, MDa, Harri Niinikoski, MDa, Olli-Pekka Pitkänen, MDa, Hidehiro Iida, DSca*, Jorma Viikari, MDa, Pirjo Nuutila, MDa and Juhani Knuuti, MDa

a Departments of Medicine, Clinical Physiology, Cardiorespiratory Research Unit and Nuclear Medicine, Turku Positron Emission Tomography Centre, Turku University, Turku, Finland
* Research Institute for Brain and Blood Vessels, Akita, Japan

Manuscript received October 6, 1997; revised manuscript received March 25, 1998, accepted April 9, 1998.

Address for correspondence: Dr. Hanna Laine, Department of Medicine, University of Turku, FIN-20520 Turku, Finland
hannal{at}pet.tyks.fi

Objectives. The purpose of this study was to investigate whether functional abnormalities in coronary vasomotion are present in young healthy asymptomatic men fulfilling the World Health Organization (WHO) criteria for borderline hypertension.

Background. Previous studies have reported reduced coronary flow reserve in middle-aged subjects with sustained hypertension and hypertension-induced microvascular heart disease or left ventricular hypertrophy.

Methods. Myocardial blood flow was measured at baseline and during dipyridamole-induced hyperemia by means of positron emission tomography and oxygen-15–labeled water in asymptomatic young men with borderline hypertension (group 1: n = 16, mean ± SD age 37 ± 4 years, 24-h ambulatory blood pressure 135 ± 10/81 ± 9 mm Hg) and matched healthy control subjects (group 2: n = 19, age 35 ± 3 years, 24-h ambulatory blood pressure 119 ± 8/69 ± 8 mm Hg, p < 0.001). Left ventricular (LV) mass, dimensions and function were measured by echocardiography.

Results. LV mass, dimensions and diastolic function were similar in the study groups. Baseline myocardial blood flow was similar (0.83 ± 0.21 vs. 0.80 ± 0.22 ml/g per min, group 1 vs. group 2, respectively, p = NS), and a significant increase in flow was detected after dipyridamole infusion (0.56 mg/kg body weight in 4 min intravenously) in both groups. However, the flow response to dipyridamole was significantly lower in group 1, leading to lower hyperemic flow in group 1 than in group 2 (2.85 ± 1.20 vs. 3.80 ± 1.44 ml/g per min, respectively). Consequently, the coronary flow response was lower in hypertensive than in normotensive men (3.46 ± 1.23 vs. 4.99 ± 2.5 ml/g per min, group 1 vs. group 2, respectively, p < 0.05).

Conclusions. These results demonstrate reduced coronary reactivity present in young asymptomatic men with borderline hypertension and no signs of hypertension-induced angina or left ventricular hypertrophy. Because baseline basal myocardial blood flow was unchanged, the reduction in coronary flow reserve depends on an impaired maximal vasodilator capacity.

Abbreviations and Acronyms
  ECG = electrocardiogram, electrocardiographic
  [15O]CO = oxygen-15–labeled carbon monoxide
  HDL = high density lipoprotein
  [15O]H2O = oxygen-15–labeled water
  LDL = low density lipoprotein
  LV = left ventricular
  LVM = left ventricular mass
  PET = positron emission tomography (tomographic)
  ROI = region of interest
  WHO = World Health Organization




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. Koivuviita, R. Tertti, M. Jarvisalo, M. Pietila, J. Hannukainen, J. Sundell, P. Nuutila, J. Knuuti, and K. Metsarinne
Increased basal myocardial perfusion in patients with chronic kidney disease without symptomatic coronary artery disease
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2773 - 2779.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Raher, H. Thibault, K. K. Poh, R. Liu, E. F. Halpern, G. Derumeaux, F. Ichinose, W. M. Zapol, K. D. Bloch, M. H. Picard, et al.
In Vivo Characterization of Murine Myocardial Perfusion With Myocardial Contrast Echocardiography: Validation and Application in Nitric Oxide Synthase 3 Deficient Mice
Circulation, September 11, 2007; 116(11): 1250 - 1257.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. M. Vigano, M. Turiel, V. Martina, E. Meregalli, L. Tomasoni, G. De Blasio, L. Delfino, A. Edefonti, P. Grillo, M. Procaccio, et al.
Reduced coronary flow reserve in young adults with renal transplant
Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2328 - 2333.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Lerman, D. R. Holmes, J. Herrmann, and B. J. Gersh
Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?
Eur. Heart J., April 1, 2007; 28(7): 788 - 797.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Erdogan, I. Yildirim, O. Ciftci, I. Ozer, M. Caliskan, H. Gullu, and H. Muderrisoglu
Effects of Normal Blood Pressure, Prehypertension, and Hypertension on Coronary Microvascular Function
Circulation, February 6, 2007; 115(5): 593 - 599.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. O. Kiviniemi, A. Snapir, M. Saraste, J. O. Toikka, O. T. Raitakari, M. Ahotupa, J. J. Hartiala, M. Scheinin, and J. W. Koskenvuo
Determinants of coronary flow velocity reserve in healthy young men
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H564 - H569.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Indermuhle, R. Vogel, P. Meier, S. Wirth, R. Stoop, M. G. Mohaupt, and C. Seiler
The relative myocardial blood volume differentiates between hypertensive heart disease and athlete's heart in humans
Eur. Heart J., July 1, 2006; 27(13): 1571 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Rodriguez-Porcel, X.-Y. Zhu, A. R. Chade, B. Amores-Arriaga, N. M. Caplice, E. L. Ritman, A. Lerman, and L. O. Lerman
Functional and structural remodeling of the myocardial microvasculature in early experimental hypertension
Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H978 - H984.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
T. Pellegrino, G. Storto, P. P. Filardi, A. R. Sorrentino, A. Silvestro, M. Petretta, G. Brevetti, M. Chiariello, M. Salvatore, and A. Cuocolo
Relationship Between Brachial Artery Flow-Mediated Dilation and Coronary Flow Reserve in Patients with Peripheral Artery Disease
J. Nucl. Med., December 1, 2005; 46(12): 1997 - 2002.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. C. Brunken, J. K. Perloff, J. Czernin, R. Campisi, S. Purcell, P. D. Miner, J. S. Child, and H. R. Schelbert
Myocardial perfusion reserve in adults with cyanotic congenital heart disease
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1798 - H1806.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. L. E. Vicario, L. Cirillo, G. Storto, T. Pellegrino, N. Ragone, L. Fontanella, M. Petretta, D. Bonaduce, and A. Cuocolo
Influence of Risk Factors on Coronary Flow Reserve in Patients with 1-Vessel Coronary Artery Disease
J. Nucl. Med., September 1, 2005; 46(9): 1438 - 1443.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. H. Buus, M. Bottcher, C. G. Jorgensen, K. L. Christensen, K. Thygesen, T. T. Nielsen, and M. J. Mulvany
Myocardial Perfusion During Long-Term Angiotensin-Converting Enzyme Inhibition or {beta}-Blockade in Patients With Essential Hypertension
Hypertension, October 1, 2004; 44(4): 465 - 470.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Sundell, E. Engblom, J. Koistinen, A. Ylitalo, A. Naum, K. Q. Stolen, R. Kalliokoski, S. G. Nekolla, K. E. J. Airaksinen, J. J. Bax, et al.
The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 1027 - 1033.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
H Laine, J Sundell, P Nuutila, O T Raitakari, M Luotolahti, T Ronnemaa, T Elomaa, P Koskinen, and J Knuuti
Insulin induced increase in coronary flow reserve is abolished by dexamethasone in young men with uncomplicated type 1 diabetes
Heart, March 1, 2004; 90(3): 270 - 276.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. Tadamura, M. Mamede, S. Kubo, H. Toyoda, M. Yamamuro, H. Iida, N. Tamaki, K. Nishimura, M. Komeda, and J. Konishi
The Effect of Nitroglycerin on Myocardial Blood Flow in Various Segments Characterized by Rest-Redistribution Thallium SPECT
J. Nucl. Med., May 1, 2003; 44(5): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. E. Langerak, H. W. Vliegen, J. W. Jukema, P. Kunz, A. H. Zwinderman, H. J. Lamb, E. E. van der Wall, and A. de Roos
Value of Magnetic Resonance Imaging for the Noninvasive Detection of Stenosis in Coronary Artery Bypass Grafts and Recipient Coronary Arteries
Circulation, March 25, 2003; 107(11): 1502 - 1508.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Paiva, J. Laakso, H. Laine, R. Laaksonen, J. Knuuti, and O. T. Raitakari
Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia
J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1241 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Aronson, D. Boisvert, and W. Lapp
Isolated Systolic Hypertension Is Associated with Adverse Outcomes from Coronary Artery Bypass Grafting Surgery
Anesth. Analg., May 1, 2002; 94(5): 1079 - 1084.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Sundell, P. Nuutila, H. Laine, M. Luotolahti, K. Kalliokoski, O. Raitakari, and J. Knuuti
Dose-Dependent Vasodilating Effects of Insulin on Adenosine-Stimulated Myocardial Blood Flow
Diabetes, April 1, 2002; 51(4): 1125 - 1130.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Scognamiglio, A. Avogaro, S. Vigili de Kreutzenberg, C. Negut, M. Palisi, E. Bagolin, and A. Tiengo
Effects of Treatment With Sulfonylurea Drugs or Insulin on Ischemia-Induced Myocardial Dysfunction in Type 2 Diabetes
Diabetes, March 1, 2002; 51(3): 808 - 812.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. H. Buus, M. Bottcher, F. Hermansen, M. Sander, T. T. Nielsen, and M. J. Mulvany
Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia
Circulation, November 6, 2001; 104(19): 2305 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. W. Koskenvuo, J. J. Hartiala, J. Knuuti, H. Sakuma, J. O. Toikka, M. Komu, M. Saraste, and P. Niemi
Assessing Coronary Sinus Blood Flow in Patients with Coronary Artery Disease: A Comparison of Phase-Contrast MR Imaging with Positron Emission Tomography
Am. J. Roentgenol., November 1, 2001; 177(5): 1161 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. Schwartz and M. G. Bourassa
Evaluation of Patients With Chest Pain and Normal Coronary Angiograms
Arch Intern Med, August 13, 2001; 161(15): 1825 - 1833.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M Fujiwara, T Tamura, K Yoshida, K Nakagawa, M Nakao, M Yamanouchi, N Shikama, T Himi, and Y Masuda
Coronary flow reserve in angiographically normal coronary arteries with one-vessel coronary artery disease without traditional risk factors
Eur. Heart J., March 2, 2001; 22(6): 479 - 487.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
E. Tadamura, H. Iida, K. Matsumoto, M. Mamede, S. Kubo, H. Toyoda, T. Shiozaki, T. Mukai, Y. Magata, and J. Konishi
Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men
J. Am. Coll. Cardiol., January 1, 2001; 37(1): 130 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Laine, P. Nuutila, M. Luotolahti, C. Meyer, T. Elomaa, P. Koskinen, T. Rönnemaa, and J. Knuuti
Insulin-Induced Increment of Coronary Flow Reserve Is Not Abolished by Dexamethasone in Healthy Young Men
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1868 - 1873.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al.
Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy
Circulation, December 14, 1999; 100(24): 2425 - 2430.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Ward and N. A. Herity
Percutaneous Transluminal Coronary Angioplasty Reverses Vasoconstriction of Stenotic Coronary Arteries in Hypertensive Patients
Circulation, October 26, 1999; 100 (17): 84e - e85.
[Full Text] [PDF]


Home page
CirculationHome page
I. Yokoyama, S.-i. Momomura, T. Ohtake, K. Yonekura, W. Yang, N. Kobayakawa, T. Aoyagi, S. Sugiura, N. Yamada, K. Ohtomo, et al.
Improvement of Impaired Myocardial Vasodilatation Due to Diffuse Coronary Atherosclerosis in Hypercholesterolemics After Lipid-Lowering Therapy
Circulation, July 13, 1999; 100(2): 117 - 122.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement